Lycia Therapeutics, Inc. Common Stock (LYCA)

• Market cap: $1.5B
• 1 day: -3.83%
• 5 days: 1.05%
• 1 month: -3.83%
• 3 months: -3.83%
• 6 months: -3.83%
• Year to date: -3.83%
• 1 year: -3.83%
• 5 years: -3.83%
• 10 years: -3.83%
• Sector: Healthcare
• Industry: Biotechnology

About: Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.